Navigation Links
Abbott Announces Positive One-Year Results from the World's First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent
Date:10/22/2007

s dissolvable sutures. As with a metallic stent, Abbott's bioabsorbable stent is designed to restore blood flow by propping a clogged vessel open, and to provide support until the blood vessel heals. Unlike a metallic stent, however, a bioabsorbable stent is designed to be slowly metabolized by the body and completely absorbed over time.

As reported in March 2007, late loss, a measure of reduction in lumen (vessel) diameter after stenting, was 0.44 mm for ABSORB at six months.

"ABSORB is an exciting future generation device that has the potential to advance the treatment of coronary artery disease beyond the benefits that next-generation metallic drug eluting stent platforms can provide," said John M. Capek, PhD., executive vice president, Medical Devices, Abbott. "Positive data with Abbott's bioabsorbable technology is encouraging and supports the direction we are moving toward in helping physicians open blocked arteries with stents, while also allowing the stent itself to disappear over time."

About the ABSORB Clinical Trial

The ABSORB trial is a prospective, non-randomized (open label) study designed to enroll up to 60 patients in Belgium, Denmark, France, New Zealand, Poland and The Netherlands. Key endpoints of the study include assessments of safety -- MACE (defined as any event that resulted in re-treatment of a diseased artery, heart attack or cardiac death) and stent thrombosis (blood clot formation) rates -- at 30,180 and 270 days, with additional annual follow-up for up to five years, as well as an assessment of the acute performance of the bioabsorbable drug-eluting stent. Other key endpoints of the study include successful deployment of the bioabsorbable drug eluting stent, follow-up measurements assessed by angiography, intravascular ultrasound (IVUS), and state-of-the-art imaging modalities at 180 days and two years.

For images of Abbott's bioabsorbable stent and other information, please visit the company's online TCT ne
'/>"/>

SOURCE Abbott
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Three Studies Suggest Abbotts Humira (adalimumab) May Improve Work Productivity in Patients with Rheumatoid Arthritis
2. Abbott Announces Positive Nine-Month Results From the Worlds First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent
3. Abbott Announces Continued Positive Results with Xience V Everolimus Eluting Coronary Stent in Spirit Clinical Trials
4. New Analysis of Data Shows Treatment With Abbotts Humira (Adalimumab) Significantly Reduced Disease-Related Hospitalization for Patients with Crohns Disease
5. Abbotts Investigational Treatment ABT-874 Shows Positive Results in Phase II Psoriasis Study
6. Abbott Researchers Focus on New Cutting-Edge Approaches in the Fight Against Cancer
7. Two Abbott Studies Reaffirm Carotid Artery Stenting as a Safe and Effective Treatment to Reduce Risk of Stroke
8. Abbott Announces Positive Six-Month Results From the Worlds First Clinical Trial of a Fully Bioabsorbable Drug-Eluting Coronary Stent
9. Abbotts Xience V Everolimus Eluting Coronary Stent Superior to Taxus Stent in Spirit III U.S. Pivotal Clinical Trial
10. Abbott to Present New Data Across its Vascular Portfolio at the American College of Cardiologys 56th Annual Scientific Session
11. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... -- Baebies, Inc. today announced the completion of a ... round of financing included key investors Rex Health Ventures, ... Triad, LLC, the Duke Angel Network and a loan ... Liquid Logic,s (ALL) former investors including Charleston Angel Partners, ... "Rex is pleased to support this promising young company," ...
(Date:7/28/2015)...  Zipnosis, the first virtual care solution to empower health ... own branded virtual care service line, announced an agreement with ... is currently in use. ... As health systems consider ... value of providing their own branded online care for common ...
(Date:7/28/2015)... , July 28, 2015 ANI Pharmaceuticals, ... Company plans to release its second quarter and year-to-date ... the opening of the U.S. financial markets. The earnings ... section of the Company,s website, www.anipharmaceuticals.com . ... Executive Officer, and Charlotte C. Arnold , Vice ...
Breaking Medicine Technology:Baebies, Inc. Raises $13 Million in Oversubscribed Round of Financing 2Zipnosis Announces Group Health to use Virtual Care Service Line 2Zipnosis Announces Group Health to use Virtual Care Service Line 3ANI Pharmaceuticals Schedules Conference Call for Second Quarter and Year-to-Date 2015 Financial Results 2
... Mind Technologies, Inc . ( http://mindtechnologiesinc.com ) (Pink Sheets: ... on The Company,s proprietary EEG/ BCI headset, which is ... the world leader in EEG/ BCI technology, Mind Technologies ... process of developing a state-of-the-art headset that would revolutionize ...
... Awarepoint Corporation , the leading ... announced that the U.S. Patent and Trademark Office has ... interaction-based tracking system that helps hospitals enhance their patient ... outcomes. (Logo:   http://photos.prnewswire.com/prnh/20100127/LA44915LOGO ) ...
Cached Medicine Technology:Mind Technologies Inc. Developing Revolutionary EEG Brain Computer Interface 2Awarepoint Awarded U.S. Patent for its Revolutionary Tag-to-Tag Communication Technology 2
(Date:7/28/2015)... , ... July 28, 2015 , ... Please join us for the 5th Annual ... Town Center located at Gary Avenue and Lies Road in Carol Stream. All are welcome. ... raise awareness, and provide education and help to support individuals and families affected by a ...
(Date:7/28/2015)... ... July 28, 2015 , ... One ... including Runner’s World Magazine, is plantar fasciitis . Zensah, the Miami-based compression ... Designed by a professional athletic trainer, the Zensah Ankle Support’s primary benefits include ...
(Date:7/28/2015)... ... July 28, 2015 , ... Intellitec Solutions has been ... annual ranking of Value Added Resellers of ERP Software is a look at the ... with. This honor represents the second such award in 2015 for Intellitec Solutions, following ...
(Date:7/28/2015)... Louis, MO (PRWEB) , ... July 28, 2015 , ... ... back pain comes in as a close second. Clients suffering from headaches and back ... clients get started with chiropractic treatment, The Joint 's nine offices in the ...
(Date:7/28/2015)... (PRWEB) , ... July 28, 2015 , ... ... the post surgical spine patient with discussion and demonstration of specific rehabilitation exercises ... Gain insight into the actual surgical process with an extensive interview conducted by ...
Breaking Medicine News(10 mins):Health News:5th Annual Step for Hope 5K Run/Walk Event in Carol Stream, IL to Benefit Renowned Brain Aneurysm Foundation 2Health News:Zensah Releases Compression Sleeve To Relieve Ankle Pain and Plantar Fasciitis 2Health News:Intellitec Solutions Named by Accounting Today as Top 100 Value Added Reseller 2Health News:The Joint St. Louis Offers “2 for Thursday” Special, Chiropractic Care Services, Affordable Back Pain Relief 2Health News:North American Seminars Introduces a New OT PT PTA Online Continuing Education Course on the Treatment of Post Surgical Cervical and Lumbar Spine Patients 2Health News:North American Seminars Introduces a New OT PT PTA Online Continuing Education Course on the Treatment of Post Surgical Cervical and Lumbar Spine Patients 3Health News:North American Seminars Introduces a New OT PT PTA Online Continuing Education Course on the Treatment of Post Surgical Cervical and Lumbar Spine Patients 4Health News:North American Seminars Introduces a New OT PT PTA Online Continuing Education Course on the Treatment of Post Surgical Cervical and Lumbar Spine Patients 5Health News:North American Seminars Introduces a New OT PT PTA Online Continuing Education Course on the Treatment of Post Surgical Cervical and Lumbar Spine Patients 6
... COLUMBUS, Ohio, Jan. 19 Abbott ... voluntary recall of,ZonePerfect(R) Chocolate Peanut Butter bars, ZonePerfect(R) ... in response to the widening,recall involving peanut butter ... America (PCA). PCA was one of the ...
... with early-stage lung cancer are not seen when patients ... the January issue of Archives of Surgery , ... more deaths in the United States than any other ... resectionor surgery to remove a portion of the lungprovides ...
... setting, study finds , , MONDAY, Jan. 19 (HealthDay News) ... on the rise among American children, a new report ... the bacteria Staphylococcus aureus -- referred to ... methicillin -- are moving beyond the traditional confines of ...
... /PRNewswire-FirstCall/ - The Board of Directors of NUCRYST ... B. Holtz as interim President and Chief Executive ... Chairman, effective immediately. Mr. Holtz replaces Thomas E. ... Officer. Mr. Carragher, currently lead director of NUCRYST, ...
... Aribex, Inc., a world leader in handheld x-ray ... second U.S. patent for its NOMAD Handheld X-ray System. ... concept of having all components of the x-ray system ... development of the world,s first handheld x-ray system. Aribex ...
... ethnicity, types of seafood consumed , , MONDAY, Jan. 19 (HealthDay ... for a living, and her ethnicity may all be ... new survey says. , The report, published in the January ... in coastal areas in the Northeastern United States had ...
Cached Medicine News:Health News:Abbott Nutrition Announces Voluntary Recall of ZonePerfect(R) Chocolate Peanut Butter Bars, ZonePerfect(R) Peanut Toffee Bars and NutriPals(TM) Peanut Butter Chocolate Bars in U.S., Mexico, New Zealand and Singapore 2Health News:Study examines racial disparities in survival among patients diagnosed with lung cancer 2Health News:MRSA Infections Spreading to Kids in Community 2Health News:MRSA Infections Spreading to Kids in Community 3Health News:NUCRYST appoints interim CEO 2Health News:NUCRYST appoints interim CEO 3Health News:Aribex(R) Awarded Patents for Handheld X-ray 2Health News:Women in Coastal Areas Have Higher Mercury Levels 2
... Blades are designed for the retraction ... basal lesions. Reduced obstruction when working ... instrument, range of blade sizes from ... Quick change and release, malleable material ...
Permanently sharp, slightly angulated blade, delicate sharp dissection, excellent balanced, ergonomic design....
Epstein Curettes 3.0 mm, length 8" (203 mm)....
Codman-Cone Ring Curettes, ring diameter (I.D.) 5 / 16" (8 mm), total length 9" (229 mm)....
Medicine Products: